NGNE · Neurogene Inc. · Proposed Sales

$35.48 -0.64 (-1.77%) At close · Sep 11

Russell 2000 member Rebalance outlook locked

Market Cap

$710.00M

20.01M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed	Seller	Relationship	Shares	Market Value	Approx. Sale	Broker
2026-03-13	STUART COBB	Officer	6,797	$151,573	2026-03-13	Morgan Stanley Smith Barney LLC Executive Financial Services
2026-02-27	Christine Cvijic	Officer	9,600	$188,928	2026-02-27	J.P. Morgan Securities LLC
2025-05-14	STUART COBB	Officer	6,797	$105,421	2025-05-14	Morgan Stanley Smith Barney LLC Executive Financial Services
2024-03-07	MARTIN BABLER	Director	2,500	$98,234	2024-03-07	Morgan Stanley Smith Barney LLC Executive Financial Services
2024-03-04	SEAN SMITH	Officer	371	$13,567	2024-03-04	Morgan Stanley Smith Barney LLC Executive Financial Services
2024-02-09	TODD SIMPSON	Director	2,500	$77,500	2024-02-09	Morgan Stanley Smith Barney LLC Executive Financial Services
2024-02-06	ERIN LAVELLE	Director	2,500	$76,125	2024-02-06	Morgan Stanley Smith Barney LLC Executive Financial Services

Showing 1–7 of 7 filings

Key facts CIK 1404644 CUSIP 64135M105 13F (30d) 65 filings 65 filers Visit website Investor relations